Rossari Biotech to establish Singapore subsidiary, expanding global presence

Rossari Biotech Limited's board of directors approved the incorporation of a wholly owned subsidiary in Singapore. This new entity, tentatively named Rossari (Singapore) Pte. Limited, will require an initial investment of up to $10 million, disbursed in tranches. The company aims for the subsidiary's incorporation to be completed by Q4 FY26, subject to regulatory approvals.

The Singapore-based subsidiary will operate within the chemical and other industry and is envisioned as a strategic vehicle for global investment and expansion. Rossari Biotech Limited will hold 100% of the total equity share capital of the new entity, making it a related party to the company. Any transactions with the subsidiary will be conducted on an arm’s length basis.

This move aligns with Rossari Biotech's objective of increasing its global footprint. The company will provide further updates upon the subsidiary's official incorporation.